TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
ZTS

Zoetis Inc

Healthcare · Drug Manufacturers - Specialty & Generic

73.00$ +0.0% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Income Statement

Zoetis Inc (ZTS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 9,467 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement ZTS
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
4,785 4,765 4,888 5,307 5,825 6,260 6,675 7,776 8,080 8,544 9,256 9,467
1,777 1,798 1,745 1,864 2,028 2,147 2,217 2,464 2,604 2,710 2,860 2,794
3,008 2,967 3,143 3,443 3,797 4,113 4,458 5,312 5,476 5,834 6,396 6,673
396 364 376 382 432 457 463 508 539 614 686 698
1,380 1,296 1,197 1,171 1,324 1,471 1,493 1,709 1,722 1,870 2,016 2,378
2,038 1,885 1,739 1,716 1,916 2,095 2,189 2,509 2,548 2,765 3,004 3,076
970 1,082 1,404 1,727 1,881 2,018 2,269 2,803 2,928 3,069 3,392 3,597
117 124 166 175 212 242 249 236 237 258 242 243
820 545 1,228 1,525 1,690 1,801 1,996 2,488 2,656 2,936 3,133 3,360
233 206 409 663 266 301 360 454 545 596 637 687
583 339 821 864 1,428 1,500 1,638 2,037 2,114 2,344 2,486 2,673
1,141 868 1,634 1,942 2,210 2,455 2,686 3,172 3,358 3,685 3,872 4,069

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?